Internal Medicine, Hematology · Indianapolis, IN
NPI
1881650356
Since 2006
Specialty
Internal Medicine, Hematology
Code 207RH0000X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
535 Barnhill Dr, Rt473
Indianapolis, IN, 46202
Phone (317) 278-7576
Groups this clinician bills Medicare through
Medicare paid, 2024
$17K
240 services
Medicare patients, 2024
79
Average age 61
Drug cost, 2024
$7.5M
1,948 prescriptions
Company payments, 2025
$41.11
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jennifer E Schwartz was code 99214 (office e&m - established), 125 times for 56 patients. In total Jennifer E Schwartz billed 240 services in 8 codes, and Medicare paid $17K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 125 | 56 | $67.89 | $8,486 |
| 99232 Hospital E&M - Subsequent | Facility | 47 | 17 | $56.77 | $2,668 |
| 99215 Office E&M - Established | Facility | 23 | 14 | $106.11 | $2,441 |
By year: 2022 $13K for 165 services; 2023 $21K for 270 services; 2024 $17K for 240 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jennifer E Schwartz prescribed most often to Medicare patients was Acyclovir, with 199 prescriptions and refills. In total Jennifer E Schwartz wrote 1,948 Medicare prescriptions that cost $7.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 199 | 365 | 52 | $5,964 |
| Rezurock Belumosudil Mesylate | 145 | 147 | 19 | $4.2M |
| Jakafi Ruxolitinib Phosphate | 142 | 142 | 22 | $2.5M |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 132 | 182 | 31 | $931 |
| Fluconazole Generic | 71 | 107 | 20 | $4,110 |
| Pantoprazole Sodium Generic | 66 | 104 | 19 | $550 |
| Sirolimus Generic | 64 | 78 | 13 | $11K |
| Gabapentin Generic | 59 | 91 | 13 | $798 |
| Tacrolimus Generic | 47 | 65 | 15 | $6,120 |
| Cresemba Isavuconazonium Sulfate | 36 | 50 | 13 | $323K |
| Mycophenolate Mofetil Generic | 35 | 61 | 12 | $2,529 |
| Methylprednisolone Generic | 35 | 36 | 11 | $1,839 |
| Potassium Chloride Generic | 35 | 53 | 11 | $1,467 |
| Posaconazole Generic | 29 | 29 | Under 11 | $33K |
| Trazodone Hcl Generic | 29 | 35 | Under 11 | $37.83 |
Brand drugs: - claims; generic drugs: 1,505 claims; opioid claims: 31.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jennifer E Schwartz $41.11 ($41.11 in general payments such as food, travel and fees) from 3 companies. The largest payer was Sanofi-Aventis U.S. LLC with $41.11.
| Company | Payments | Amount |
|---|---|---|
| Sanofi-Aventis U.S. LLC SNY | 1 | $41.11 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.